These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 33272178)

  • 1. Therapeutic Measures for the Novel Coronavirus: A Review of Current Status and Future Perspective.
    Shahverdi M; Darvish M
    Curr Mol Med; 2021; 21(7):562-572. PubMed ID: 33272178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments.
    Canedo-Marroquín G; Saavedra F; Andrade CA; Berrios RV; Rodríguez-Guilarte L; Opazo MC; Riedel CA; Kalergis AM
    Front Immunol; 2020; 11():569760. PubMed ID: 33362758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
    Patil AM; Göthert JR; Khairnar V
    Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS coronavirus 2: from genome to infectome.
    Rastogi M; Pandey N; Shukla A; Singh SK
    Respir Res; 2020 Dec; 21(1):318. PubMed ID: 33261606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies.
    Raman R; Patel KJ; Ranjan K
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19.
    Majumder J; Minko T
    AAPS J; 2021 Jan; 23(1):14. PubMed ID: 33400058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic and Vaccine Options for COVID-19: Status after Six Months of the Disease Outbreak.
    Maciorowski D; Ogaugwu C; Durvasula SR; Durvasula R; Kunamneni A
    SLAS Discov; 2021 Mar; 26(3):311-329. PubMed ID: 33319627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far.
    Khan M; Adil SF; Alkhathlan HZ; Tahir MN; Saif S; Khan M; Khan ST
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33374759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Coronavirus: A Review from Origin to Current Status of Therapeutic Strategies.
    Hassan M; Zalkifal M; Wahab A; Afzal S; Rafique S; Shahid M; Khan MA; Ahmed N; Idrees M; Shahid AA
    Crit Rev Eukaryot Gene Expr; 2021; 31(3):21-34. PubMed ID: 34369712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspective on the Role of Antibodies and Potential Therapeutic Drugs to Combat COVID-19.
    Tandon S; Aggarwal A; Jain S; Shukla S; Chaudhary S
    Protein J; 2020 Dec; 39(6):631-643. PubMed ID: 33034824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2: Insight in genome structure, pathogenesis and viral receptor binding analysis - An updated review.
    Bhat EA; Khan J; Sajjad N; Ali A; Aldakeel FM; Mateen A; Alqahtani MS; Syed R
    Int Immunopharmacol; 2021 Jun; 95():107493. PubMed ID: 33721758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development.
    Karnik M; Beeraka NM; Uthaiah CA; Nataraj SM; Bettadapura ADS; Aliev G; Madhunapantula SV
    Mol Neurobiol; 2021 Sep; 58(9):4535-4563. PubMed ID: 34089508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
    Gudadappanavar AM; Benni J
    J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses.
    Shereen MA; Khan S; Kazmi A; Bashir N; Siddique R
    J Adv Res; 2020 Jul; 24():91-98. PubMed ID: 32257431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe Acute Respiratory Syndrome Coronavirus (SARS, SARS CoV).
    McFee RB
    Dis Mon; 2020 Sep; 66(9):101062. PubMed ID: 32800504
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.
    Yadav R; Chaudhary JK; Jain N; Chaudhary PK; Khanra S; Dhamija P; Sharma A; Kumar A; Handu S
    Cells; 2021 Apr; 10(4):. PubMed ID: 33917481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19: morphology and mechanism of the SARS-CoV-2, global outbreak, medication, vaccines and future of the virus.
    Bhattacharyya P; Das S; Aich S; Sarkar J
    Front Biosci (Elite Ed); 2021 Dec; 13(2):272-290. PubMed ID: 34937314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome sequencing of SARS-CoV-2 reveals the prevalence of variant B 1.1.7 in Egypt.
    Seadawy MG; Gad AF; Abo-Elmaaty SA; Hassan MG
    Infect Genet Evol; 2022 Jan; 97():105191. PubMed ID: 34923158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The COVID-19 pandemic: a global health crisis.
    Pollard CA; Morran MP; Nestor-Kalinoski AL
    Physiol Genomics; 2020 Nov; 52(11):549-557. PubMed ID: 32991251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omicron Genetic and Clinical Peculiarities That May Overturn SARS-CoV-2 Pandemic: A Literature Review.
    Tiecco G; Storti S; Degli Antoni M; Focà E; Castelli F; Quiros-Roldan E
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.